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Effect of Socioeconomic Status and Comorbidities on Thyroid Cancer Survival Outcomes  
Daniel Quan, BS, Andrea Plawecki, MD, Ayaka Iwata, MS, MD, Meredith Van Harn, MS, Amy Williams, 
PhD, Steven Chang, MD 
Purpose/Objectives: Thyroid cancer ranks among the most common head and neck malignancies and 
makes up 3% of new cancer cases per year, having increased in overall incidence in the last several 
decades. This study investigates patient characteristics, socioeconomic status (SES), and medical 
comorbidities as independent predictors of survival in patients with thyroid cancer, treated at a tertiary 
care hospital with a diverse, primarily low SES patient population. 
Materials/Methods: The Henry Ford Health System’s Virtual Data Warehouse Tumor Registry was used 
to identify patients with thyroid cancers from 1997 to 2016. Socioeconomic data was obtained from 
2010 US Census. Comorbidities were quantified using the Charlson Comorbidity Index (CCI). Statistical 
analysis was performed using Kaplan-Meier estimator and Cox proportional hazards models.    
Results: There were 1042 patients with thyroid cancer. 5- and 10-year survival probabilities decreased 
with age >=60 years (p<0.001), stage 3/4 (p<0.001), clinical N stage 1-3 (p<0.001), black race (p=0.001), 
CCI>1 (p<0.001), and lowest quartile median household income (p<0.001). In multivariate analysis, age 
(1-year increase HR: 1.97, 95% CI: 1.06-1.09), sex (female vs. male HR: 0.67, 95% CI: 0.48-0.95), and CCI 
(1-point increase HR: 1.26, 95% CI: 1.19-1.34) were significantly associated with survival outcomes. A CCI 
cutoff of >1 was a reliable predictor of mortality (AUC: 0.759, 95% CI: 0.716-0.801). CCI was significantly 
correlated with stage (r=0.166, p=0.004) and median household income (r=-0.175, p<0.001).  
Conclusion: Increased age, male sex, and medical comorbidities predicted significantly worse survival in 
thyroid cancer. Race and median household income were not independent significant prognostic 
indicators. 
 
 
 
 
